High-Throughput 3D Spheroid Drug Screening Platform

Exhibitor: CELLBALL BIOMEDICAL CO., LTD.

Booth No: N906

Characteristic

CellBall Biomedical is collaborating with Integrated Bio Ltd. and the Center of Comparative Medicine and Research at National Cheng Kung University. By integrating the RASTRUMTM automated 3D cell printing system and high-throughput drug screening services, we are committed to faithfully reconstructing the tissue microenvironments with more realistic and controllable 3D cellular models, making cancer drug responses more physiologically relevant and boosting the efficiency and reliability of research for drug development and precision medicine.
Compared to conventional 2D cultures, 3D cell models more accurately simulate native human tissue structure and behavior, delivering more physiologically relevant drug responses. This makes them ideal for studies in tumor organoids, immune cell interactions, and regenerative medicine.
The RASTRUM™ system combines advanced microfluidics with non-contact bioprinting technology, using tailored bio-matrix to meet different cell types and tissue conditions. Paired with high-throughput drug screening, it significantly accelerates testing timeframes and reduces human error, ensuring more consistent and accurate results.
We offer customized disease models according to clients’ requirements, including cancer organoids and immune co-culture systems, for drug efficacy testing, toxicity assessment, and mechanism investigation. From model design and printing optimization to drug application and data analysis, we provide end-to-end technical support.
This platform supports both basic research and clinical application, making it a powerful tool for drug development and functional cell evaluation across multiple stages.